[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100514430":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":39,"responsibleParty":58,"collaborators":18,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":18,"enrollmentInfo":71,"targetDuration":18,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":41,"whyStopped":18,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Herlev and Gentofte Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Analysis of coronary CT angiography and CAC scoring at the time of catheter ablation","EXPERIMENTAL","Based on the results of the coronary CT angiography and CAC scoring in the intervention group, relevant anti-ischemic and multimodality treatment will be initiated according to clinical guidelines.",[13],"Diagnostic Test: Analysis of coronary CT Angiography and CAC scoring at the time of catheter ablation",{"label":15,"type":16,"description":17,"interventionNames":18},"No analysis of coronary CT angiography and CAC scoring at the time of catheter ablation","NO_INTERVENTION","Patients in the control group will follow the current standard of care prior to ablation.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DIAGNOSTIC_TEST","Analysis of coronary CT Angiography and CAC scoring at the time of catheter ablation","Analysis of coronary CT angiography and CAC scoring and initiation of relevant derived treatment at the time of catheter ablation.",[9],[26],{"name":27,"affiliation":28,"role":29},"Tor Biering-Sørensen, MD, PhD, MPH, MSc","Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte","STUDY_CHAIR",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Caroline Espersen, MD","CONTACT","+4551180082","caroline.espersen@regionh.dk",{"name":27,"role":33,"phone":37,"phoneExt":18,"email":38},"+4528933590","tor.biering-soerensen@regionh.dk",[40],{"facility":28,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"RECRUITING","Hellerup","Capital Region","2900","Denmark","DK",{"type":48,"coordinates":49},"Point",[50,51],12.57093,55.73204,{"lat":51,"lon":50},[54,55,56],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},{"name":27,"role":33,"phone":37,"phoneExt":18,"email":38},{"name":32,"role":57,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"type":59,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"SPONSOR_INVESTIGATOR","Tor Biering-Sørensen","Professor, Head of Center for Translational Cardiology and Pragmatic Randomized Trials","100514430","coronary-computed-tomography-angiography-prior-to-catheter-ablation-in-patients-with-atrial-fibrillation-100514430",false,"NCT05978388","Coronary Computed Tomography AngioGraphy Prior to Catheter Ablation in Patients With Atrial FIBrillation","FIBCAG","Inclusion Criteria:\n\n* Age over 18 years.\n* Referral for catheter ablation treatment (excluding AV-junction ablation) for atrial fibrillation (both paroxysmal and persistent atrial fibrillation) at the Department of Cardiology at Gentofte Hospital. Both first ablation and re-ablation treatments are included.\n* The ability and willingness to provide written informed consent.\n\nExclusion Criteria:\n\n* Known atherosclerotic cardiovascular disease (ASCVD).\n* Ongoing treatment with statins.\n* Contraindications for coronary CT angiography, e.g. contrast allergy\n* Recent coronary CT angiography including CAC-score without positive findings \\\u003C3 years prior to screening.\n* Any surgical or medical condition, which in the opinion of the investigator, may place the patient at higher risk from his\u002Fher participation in the study, or is likely to prevent the patient from complying with the requirements of the study or completing the study.","ALL","18 Years",{"count":72,"type":73},852,"ESTIMATED","INTERVENTIONAL",[76],"NA","The purpose of this randomized, controlled trial is to investigate whether coronary computed tomography (CT) angiography prior to catheter ablation and derived treatment (medical anti-ischemic and multimodality treatment and\u002For mechanical revascularization) can improve clinical outcomes in patients with atrial fibrillation undergoing catheter ablation.\n\nA sub-study will investigate the effect of different ablation strategies on clinical outcomes in patients with atrial fibrillation undergoing catheter ablation.",[79],"Atrial Fibrillation",[81,82,79,83,84,85,86,87,88],"Coronary Artery Disease","Coronary Computed Tomography Angiography","Ischemic heart disease","Catheter Ablation","Atherosclerosis","Cardiovascular Diseases","Randomized Controlled Trial","Statins","2024-06-25",{"date":91,"type":92},"2024-06-26","ACTUAL",{"date":94,"type":92},"2024-03-26",{"date":96,"type":73},"2028-04-01",{"name":60,"class":6},1]